![Paul Wotton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Wotton
Directeur/Membre du Conseil chez
CYNATA THERAPEUTICS LIMITED
Fortune : 744 540 $ au 31/05/2026
Profil
Paul Kevin Wotton is the founder of Avenge Bio, Inc. Current roles include CEO, Director & Managing Partner at RBL LLC since 2024; Independent Director at Vericel Corp.
since 2015; Director at eXIthera Pharmaceuticals, Inc.; Independent Non-Executive Director at Cynata Therapeutics Ltd. since 2020; Director at Combined Therapeutics, Inc. since 2023; Independent Director at Dimension Inx LLC since 2023; Member of the Royal Pharmaceutical Society of Great Britain; and Member of the Licensing Executives Society.
Former positions include President, Chief Executive Officer & Director at Antares Pharma, Inc. from 2011 to 2014; President, Chief Executive Officer & Director at Astellas Institute for Regenerative Medicine from 2014 to 2016; President, Chief Executive Officer & Director at Obsidian Therapeutics, Inc. from 2019 to 2022; Chief Executive Officer at Topigen Pharmaceuticals, Inc. from 2004 to 2008; Independent Chairman at Kytopen Corp.
from 2023 to 2025; Co-Chairman-Integration Management Office at Astellas Pharma US, Inc. in 2016; Director at Genaera Corp.
from 2008 to 2009; Independent Director at Veloxis Pharmaceuticals A from 2016 to 2020; Independent Director at PaxMedica, Inc. from 2020 to 2021; Director at Sigilon Therapeutics, Inc. from 2018 to 2019; Head-Global Business Development at SkyePharma Plc from 2002 to 2004; Director at BIOTECanada; Director at Cadent Therapeutics, Inc.; Vice President-Business Development at Penwest Pharmaceuticals Co.; Vice President-Corporate Development at Eurand NV; and Operations Manager at Kelyniam Global, Inc. Education includes undergraduate studies at the University of London, a doctorate from The University of Nottingham, and an MBA from Kingston Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERICEL CORPORATION 0,04 % | 11/05/2026 | 18 802 ( 0,04 % ) | 626 671 $ | 31/05/2026 |
| 30/06/2025 | 585 076 ( 0,24 % ) | 117 869 $ | 31/05/2026 |
Postes actifs de Paul Wotton
| Sociétés | Poste | Début |
|---|---|---|
| VERICEL CORPORATION | Directeur/Membre du Conseil | 06/01/2015 |
| CYNATA THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 18/08/2020 |
Dimension Inx LLC
 Dimension Inx LLC Medical SpecialtiesHealth Technology Develops 3D-printing biomaterials design and manufacturing platform | Directeur/Membre du Conseil | 02/05/2023 |
Combined Therapeutics, Inc.
 Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pre-clinical-stage biotechnology company in the cancer research | Directeur/Membre du Conseil | 08/03/2023 |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures stroke prevention & antithrombosis drugs | Directeur/Membre du Conseil | - |
Licensing Executives Society
 Licensing Executives Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides world leading events, useful resources and publications for deal-making, education and best practices | Corporate Officer/Principal | - |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services Provides expertise and support to its member pharmacists | Corporate Officer/Principal | - |
RBL, LLC
 RBL, LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotech venture creation studio designed to rapidly build companies based on life-saving medical technologies | Directeur Général | 01/09/2024 |
Anciens postes connus de Paul Wotton
| Sociétés | Poste | Fin |
|---|---|---|
Kytopen Corp.
 Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Develops genetically engineered cells that modifies microorganisms | Président | 03/06/2025 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Paul Wotton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products | Health Technology |
Kelyniam Global, Inc.
 Kelyniam Global, Inc. Medical SpecialtiesHealth Technology Operates as a medical device manufacturing company | Health Technology |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures stroke prevention & antithrombosis drugs | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services Provides expertise and support to its member pharmacists | Commercial Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Licensing Executives Society
Licensing Executives Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides world leading events, useful resources and publications for deal-making, education and best practices | Commercial Services |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Cynata Therapeutics Ltd.
 Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
Kingston Business School
 Kingston Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Kytopen Corp.
Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Develops genetically engineered cells that modifies microorganisms | Commercial Services |
Combined Therapeutics, Inc.
Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pre-clinical-stage biotechnology company in the cancer research | Commercial Services |
Dimension Inx LLC
Dimension Inx LLC Medical SpecialtiesHealth Technology Develops 3D-printing biomaterials design and manufacturing platform | Health Technology |
PaxMedica, Inc.
 PaxMedica, Inc. BiotechnologyHealth Technology Develops anti-purinergic therapies treatments for neurodevelopmental disorders | Health Technology |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
RBL, LLC
RBL, LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotech venture creation studio designed to rapidly build companies based on life-saving medical technologies | Commercial Services |
